NDUFA9

Chr 12AR

NADH:ubiquinone oxidoreductase subunit A9

Also known as: CC6, CI-39k, CI39k, COQ11, MC1DN26, NDUFS2L, SDR22E1

The encoded protein is a subunit of the hydrophobic protein fraction of the NADH:ubiquinone oxidoreductase (complex I), the first enzyme complex in the electron transport chain located in the inner mitochondrial membrane. A pseudogene has been identified on chromosome 12. [provided by RefSeq, May 2010]

GeneReviewsOMIMResearchGenerating clinical summary…
DNmechanismARLOEUF 0.641 OMIM phenotype
Clinical SummaryNDUFA9
🧬
Gene-Disease Validity (ClinGen)
Leigh syndrome · ARModerate

Moderate evidence — consider for supplementary testing

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
12 unique Pathogenic / Likely Pathogenic· 133 VUS of 286 total submissions
📖
GeneReview available — NDUFA9
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.64LOEUF
pLI 0.005
Z-score 2.84
OE 0.35 (0.210.64)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.09Z-score
OE missense 0.98 (0.881.10)
226 obs / 229.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.35 (0.210.64)
00.351.4
Missense OE?0.98 (0.881.10)
00.61.4
Synonymous OE?1.04
01.21.6
LoF obs/exp: 8 / 22.6Missense obs/exp: 226 / 229.7Syn Z: -0.28
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedNDUFA9-related Leigh syndromeOTHERAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7131th %ile
GOF
0.5660th %ile
LOF
0.3357th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

286 submitted variants in ClinVar

Classification Summary

Pathogenic7
Likely Pathogenic5
VUS133
Likely Benign74
Benign41
Conflicting10
7
Pathogenic
5
Likely Pathogenic
133
VUS
74
Likely Benign
41
Benign
10
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
5
0
0
7
Likely Pathogenic
4
1
0
0
5
VUS
4
120
8
1
133
Likely Benign
0
8
29
37
74
Benign
0
3
37
1
41
Conflicting
10
Total101377439270

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

59 pathogenic / likely-pathogenic (of 66) ClinVar copy-number / structural variants overlap NDUFA9 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

NDUFA9 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →